Related articles
-
NewsA microbial blueprint for climate-smart cows
Recent research has shown that feeding cows red seaweed can dramatically cut the amount of methane that is produced and released into the environment. A new study sheds light on that process and reveals which microbes in the cow’s gut might help reduce methane.
-
NewsGreen chemistry for sustainable personal care
A recent review examined microbial biosurfactants as sustainable alternatives to synthetic surfactants in shampoo formulations. The authors addressed the growing demand for environmentally friendly and dermatologically safe cleansing agents, and emphasized the need to transition from petrochemical-based ingredients such as sodium lauryl sulfate (SLS) to biodegradable biosurfactants.
-
NewsVaccine skepticism on social media can predict public health crises
Researchers have developed a new approach that could help public health officials predict where outbreaks might occur. By analyzing social media posts, the method identifies early signs of increasing vaccine skepticism — a warning signal that could emerge before any disease begins to spread.
More from News
-
NewsMicropores pave the way for infection research
Organ-on-a-chip technology often contains gels that imitate the 3D environment of our tissues - however, many of these gels are too dense, hindering the passage of microbes and immune cells, and movement is essential to recreate how infections really develop. In this study, the research team developed a new type of porous gel that solves this problem.
-
NewsTime to act and not react: how can the European Union turn the tide of antimicrobial resistance?
Despite determined efforts by countries and healthcare professionals, Europe is not on track to meet four of the five AMR targets set by the EU Council for 2030*, according to data released on EAAD.
-
NewsApriori Bio and A*STAR Infectious Diseases Labs Announce strategic partnership to advance next generation influenza vaccines
Apriori Bio and the Agency for Science, Technology and Research Infectious Diseases Labs (A*STAR IDL) announced a strategic research partnership to co-develop and evaluate next generation self-amplifying RNA (saRNA) vaccines targeting seasonal and pandemic influenza.
No comments yet